Dermata Therapeutics (DRMA) Stock Chart & Stock Price History $0.76 -0.01 (-1.55%) As of 10:37 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dermata Therapeutics Stock Price Performance The Dermata Therapeutics (DRMA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 74.68%, with a year-to-date return of -43.56%. In the past month, the stock has decreased 4.03%, reflecting recent market activity. As of the latest close, Dermata Therapeutics traded at $0.77 with a market cap of $4.94 million and volume of 111,682 shares. Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.27%1 Month Performance-4.03%3 Month Performance-37.54%Year-To-Date Performance-43.56%1 Year Performance-74.68% DRMA Stock Chart for Thursday, June, 12, 2025 DRMA Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$0.75$0.77+3.20%$0.80$0.76111,682 shs$4.94 million06/10/2025$0.76$0.75-1.03%$0.80$0.7379,602 shs$4.78 million06/09/2025$0.75$0.76+1.70%$0.76$0.7199,183 shs$4.83 million06/06/2025$0.70$0.75+6.75%$0.75$0.6970,164 shs$4.75 million06/05/2025$0.71$0.70-1.41%$0.75$0.68183,151 shs$4.45 million06/04/2025$0.70$0.71+0.53%$0.73$0.66117,174 shs$4.52 million06/03/2025$0.70$0.70+0.61%$0.73$0.69101,413 shs$4.49 million06/02/2025$0.72$0.70-2.80%$0.76$0.7096,012 shs$4.47 million05/30/2025$0.74$0.72-2.28%$0.75$0.7241,809 shs$4.59 million05/29/2025$0.74$0.74+0.27%$0.74$0.7324,493 shs$4.70 million Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$0.75$0.74-1.34%$0.75$0.7374,224 shs$4.69 million05/27/2025$0.74$0.75+0.27%$0.76$0.7336,117 shs$4.75 million05/26/2025$0.74$0.74$0.76$0.7431,161 shs$4.74 million05/23/2025$0.77$0.74-3.26%$0.76$0.7431,161 shs$4.74 million05/22/2025$0.77$0.77-0.29%$0.78$0.7430,077 shs$4.90 million05/21/2025$0.81$0.77-4.67%$0.82$0.7556,891 shs$4.91 million05/20/2025$0.83$0.81-2.66%$0.85$0.7861,992 shs$5.15 million05/19/2025$0.79$0.83+4.93%$0.84$0.7752,846 shs$5.01 million05/16/2025$0.79$0.79-0.38%$0.84$0.7952,477 shs$4.77 million05/15/2025$0.78$0.79+1.93%$0.79$0.7557,132 shs$4.79 million05/14/2025$0.78$0.78-0.06%$0.79$0.7674,087 shs$4.70 million05/13/2025$0.79$0.78-1.83%$0.80$0.7764,794 shs$4.70 million05/12/2025$0.81$0.79-2.02%$0.82$0.75148,097 shs$4.79 million Related Companies MTEX Stock Chart LPCN Stock Chart JATT Stock Chart LEXX Stock Chart CING Stock Chart COCP Stock Chart DRRX Stock Chart SNYR Stock Chart NKGN Stock Chart BFRG Stock Chart Receive DRMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMA) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRMA Stock Free DRMA Stock Alerts